スポンサーリンク
Osaka Teishin Hospital | 論文
- Identification of High-Risk Breast Cancer Patients from Genetic Changes of Their Tumors
- Infrequent Mutations in the PTEN/MMAC1 Gene among Primary Breast Cancers
- Tegafur plus Medroxyprogesterone acetate for Adriamycin- and Tamoxifen-resistant advanced breast cancers
- CAF versus CAF plus Medroxyprogesterone Acetate for Treatment of Liver Metastases of Breast Cancer
- Conventional Dose CAF Therapy versus Low Dose Adriamycin Therapy in the Treatment of Advanced Breast Cancer